Profile
ABIO VRTX REGN SGEN ALNY ARGX
Company Name ARCA biopharma, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $34.82M $130.72B $58.75B $43.15B $35.25B $34.28B
Employees 0.00K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Mr. Thomas A. Keuer Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ABIO VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 3
Quant Rating Sell Sell Buy Neutral Strong Sell Neutral
Trading
ABIO VRTX REGN SGEN ALNY ARGX
Last Close $28.8 $485.89 $549.28 $228.74 $230.5 $587.59
High 52 $28.8 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $2.4 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High 0 % -5.97 % -54.29 % 0 % -22.33 % -12.53 %
Price vs. 52 Week Low 1100 % 23.7 % 0.53 % 0 % 60.84 % 65.05 %
Total Return
ABIO VRTX REGN SGEN ALNY ARGX
1 Month Return 0 % -5.42 % -18.95 % 0 % -8.97 % -4.33 %
3 Month Return 0 % 15.14 % -19.41 % 0 % -6.4 % -8.26 %
6 Month Return 0 % -2.58 % -44.96 % 0 % -22.31 % 8.15 %
9 Month Return 725.21 % -0.51 % -49.4 % 0 % -3.97 % 26.8 %
YTD Return 0 % 20.66 % -22.89 % 0 % -2.04 % -4.46 %
1 Year Return 797.2 % 23.6 % -39.05 % 0 % 58.62 % 60.46 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABIO VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) 72.73 % - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) 20.95 % - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Profitability
ABIO VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 52.27 % 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -21.27 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -20.18 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -26.9 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 82.18 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM -4977.84 % -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM - -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 0.15 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM 1466.67 % 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM 0.52 % 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -0.47 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -0.47 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 229.43 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM -3913.07 % -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM - -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -5.06 -165.4 16.33 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -60.66 -266.09 13.37 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -60.66 -266.09 13.37 -203.89 -4192.79 -531.16
Income Statement (TTM)
ABIO VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.37 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABIO VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0.04B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.04B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ABIO VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 18.66
ABCL AbCellera Biologics Inc. 2.415
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.89
ABOS Acumen Pharmaceuticals, Inc. 0.8871
ABPWW 0.0465
ABSI Absci Corporation 3.05
ABUS Arbutus Biopharma Corporation 3.015
ABVC ABVC BioPharma, Inc. 0.86
ABVX Abivax SA American Depositary Shares 6.26
ACAD ACADIA Pharmaceuticals Inc. 14.64
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5655
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.02
ACIU AC Immune SA 1.5
ACLX Arcellx, Inc. 60.99
ACRV Acrivon Therapeutics, Inc. Common Stock 1.755
ETFs With Exposure to ABIO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 260.14
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 115.463
VXF Vanguard Extended Market Index Fund 0 162.38
IWC iShares Micro-Cap ETF 0.00857 104.585
DFAT Dimensional U.S. Targeted Value ETF 0.00015047 47.505
VTSAX Vanguard Total Stock Market Index Fund 0 125.68
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 121.91
VITSX Vanguard Total Stock Market Index Fund 0 125.7
DFSU Dimensional US Sustainability Core 1 ETF 0.00000116 33.795
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000237478 88.58
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 121.92
SOLR SmartETFs Sustainable Energy II ETF 2.24 22.705
DCOR Dimensional ETF Trust 0.00000603 57.88
VEMPX Vanguard Extended Market Index InstlPlus 0 300.86
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.79
Unlock